ATLASenGene Therapeutics (ENGN) earnings date: expected December 6–12
enGene Therapeutics (ENGN) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around December 6–12. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ENGN
| Last price | $1.46 (-4.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the enGene Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around December 6–12 (estimate). One email the day before, with ATLAS’s read on enGene Therapeutics. You can switch it off at any time.
Alert me before ENGN reportsFree to start. Creating an account takes under a minute.
Notify me when enGene Therapeutics reports
Track ENGN free Add enGene Therapeutics to a free ATLAS watchlist and see its next report date in one place.
ENGN earnings at a glance
| Next report | Not announced · expected around December 6–12 (ATLAS estimate) |
|---|---|
| Last report | Sep 8, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +68.9% |
| Average move around a report | ±8.7% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between enGene Therapeutics’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
enGene Therapeutics earnings history: last 4 reports
enGene Therapeutics last reported on Sep 8, 2026: EPS of $0.47 against an estimate of -$0.44 (+206.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 8, 2026 | -$0.44 | $0.47 | +206.8% | Beat | +1.7% |
| Jun 15, 2026 | -$0.47 | -$0.43 | +8.5% | Beat | +8.0% |
| May 26, 2026 | -$0.08 | -$0.05 | +37.5% | Beat | +4.9% |
| Mar 9, 2026 | -$0.57 | -$0.44 | +22.8% | Beat | -20.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ENGN
See the fair value, the probability range and the earnings history of enGene Therapeutics on its ATLAS page.
enGene Therapeutics (ENGN) stock analysisPlans from €3.99 a month.
enGene Therapeutics earnings: frequently asked questions
When is enGene Therapeutics (ENGN) next earnings date?
enGene Therapeutics has not announced its next report. Its last 3 reports came Sep 8, 2026, Jun 15, 2026, Mar 9, 2026, so ATLAS estimates the next one around December 6–12. This is an estimate based on that pattern, not a confirmed date.
How often does ENGN beat earnings estimates?
Of its last 4 reports with a recorded result, enGene Therapeutics beat the EPS estimate 4 times; the average surprise was +68.9%. Past results do not predict the next one.
How much does ENGN move around earnings?
Over its last 4 reports the stock moved an average of 8.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did enGene Therapeutics beat earnings estimates last quarter?
enGene Therapeutics last reported on Sep 8, 2026: EPS of $0.47 against an estimate of -$0.44 (+206.8% surprise), a beat.
How much does ENGN usually move in a day?
On a normal trading day the ATLAS model puts ENGN’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer